RT Journal Article
T1 Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021
A1 Fernández Prada, María
A1 Rivero Calle, Irene
A1 Calvache González, Ana
A1 Martinón Torres, Federico
AB Monitoring adverse reactions following immunisation is essential, particularly for new vaccines such as those against COVID-19. We describe 20 cases of acute onset of a single supraclavicular lymphadenopathy manifesting between 24 h and 9 days after ipsilateral intramuscular administration of an mRNA-based COVID-19 vaccine, referred to our WHO Collaborating Centre for Vaccine Safety. Our results indicate that the swelling of supraclavicular lymph nodes following immunisation may constitute a benign and self-limited condition, related to a higher than recommended injection site
PB European Centre for Disease Prevention and Control (ECDC)
SN 1560-7917
YR 2021
FD 2021
LK http://hdl.handle.net/10347/26768
UL http://hdl.handle.net/10347/26768
LA eng
NO Euro Surveill. 2021; 26(10): pii=2100193. https://doi.org/10.2807/1560-7917.ES.2021.26.10.2100193
DS Minerva
RD 28 abr 2026